Home
Castle Biosciences CSTL paid McDermott+ $60K for lobbying in Q4 2023 · Medicare
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q4 2023
- Client
- Castle Biosciences
- Reported
- 24/01/05
Up 100.0% from last quarter
What else happened in Castle Biosciences around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Castle Biosciences's other lobbying reports
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 07/06
for Q2
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 04/02
for Q1
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 01/05
for Q4 2025
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 25/10/03
for Q3 2025
- Castle Biosciences
LobbyingCastle Biosciences
LobbyingCastle Biosciences
CSTL
$40K
$40K
Reported 25/06/30
for Q2 2025